Surgery may improve survival in metastatic breast cancer

04/1/2013 | U.S. News & World Report

A German study found patients with metastatic breast cancer who underwent surgery to remove lung tumors had an average survival rate of 103 months in cases of complete removal, and 20 to 23 months in those whose tumors could not be completely removed. The results suggest physicians should consider surgery in such patients, researchers wrote in The Annals of Thoracic Surgery.

View Full Article in:

U.S. News & World Report

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT